Inventor
BOY KENNETH M
US28 patents
⚠️ This page may combine multiple inventors who share the name “BOY KENNETH M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
24 patentsUS7173004B2Feb 6, 2007
Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus
BRISTOL MYERS SQUIBB CO90 citations97
US9308236B2Apr 12, 2016
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO51 citations96
US9879046B2Jan 30, 2018
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO17 citations93
US10633419B2Apr 28, 2020
Immunomodulators
BRISTOL MYERS SQUIBB CO7 citations84
US9856292B2Jan 2, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO12 citations84
US9809625B2Nov 7, 2017
Immunomodulators
BRISTOL MYERS SQUIBB CO8 citations84
US9850283B2Dec 26, 2017
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO12 citations82
US6933308B2Aug 23, 2005
Aminoalkyl thiazole derivatives as KCNQ modulators
BRISTOL MYERS SQUIBB CO11 citations74
US11358988B2Jun 14, 2022
Immunomodulators
BRISTOL MYERS SQUIBB CO2 citations73
US11103605B2Aug 31, 2021
PET-imaging immunomodulators
BRISTOL MYERS SQUIBB CO3 citations68
US7049309B2May 23, 2006
3-Thia-4-arylquinolin-2-one potassium channel modulators
BRISTOL MYERS SQUIBB CO3 citations63
US11952434B2Apr 9, 2024
Immunomodulators
BRISTOL MYERS SQUIBB CO0 citations62
US7902218B2Mar 8, 2011
Substituted tetrahydroisoquinolines as β-secretase inhibitors
BRISTOL MYERS SQUIBB CO5 citations62
US7388007B2Jun 17, 2008
Gamma-lactams as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO6 citations62
US7002015B2Feb 21, 2006
3-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxants
BRISTOL MYERS SQUIBB CO6 citations62
US8349880B2Jan 8, 2013
Bicyclic compounds for the reduction of beta-amyloid production
BRISTOL MYERS SQUIBB CO4 citations61
US7408071B2Aug 5, 2008
N-aryl pyrrolidine derivatives as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO4 citations61
US7179920B2Feb 20, 2007
3-thia-4-arylquinolin-2-one derivatives
BRISTOL MYERS SQUIBB CO0 citations52
US7145013B2Dec 5, 2006
3-thia-4-arylquinolin-2-one derivatives
BRISTOL MYERS SQUIBB CO1 citations52
US7981913B2Jul 19, 2011
Isophthalates as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US7745470B2Jun 29, 2010
Isophthalates as beta-secretase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9833454B2Dec 5, 2017
Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid production
BRISTOL MYERS SQUIBB CO0 citations50
US7273866B2Sep 25, 2007
2-aryl thiazole derivatives as KCNQ modulators
BRISTOL MYERS SQUIBB CO0 citations41
US7132542B2Nov 7, 2006
Compounds for the treatment of male erectile dysfunction
BRISTOL MYERS SQUIBB CO0 citations41
BOY KENNETH M
4 patentsUS8637525B2Jan 28, 2014
Compounds for the reduction of beta-amyloid production
BOY KENNETH M39 citations92
US8486952B2Jul 16, 2013
Compounds for the reduction of β-amyloid production
BOY KENNETH M34 citations91
US8637523B2Jan 28, 2014
Compounds for the reduction of beta-amyloid production
BOY KENNETH M2 citations61
US8710061B2Apr 29, 2014
Compounds for the reduction of β-amyloid production
BOY KENNETH M0 citations40